Wealthspire Advisors (Maryland)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-16	Closed	-$2K	–	2213
2019 Q1	$2K	Hold	16	–	–	﹤0.01%	2235
2018 Q4	$2K	Hold	16	–	–	﹤0.01%	2161
2018 Q3	$2K	Hold	16	–	–	﹤0.01%	2218
2018 Q2	$1K	Hold	16	–	–	﹤0.01%	2383
2018 Q1	$1K	Buy	16 +6	+60%	+$362	﹤0.01%	2428
2017 Q4	$1K	Buy	10 +1	+11%	+$63	﹤0.01%	2369
2017 Q3	$1K	Buy	9 +3	+50%	+$323	﹤0.01%	2173
2017 Q2	$1K	Hold	6	–	–	﹤0.01%	2143
2017 Q1	$1K	Buy	+6	New	+$700	﹤0.01%	1868
2016 Q1	–	Sell	-4	Closed	-$1K	–	1873
2015 Q4	$1K	Buy	+4	New	+$677	﹤0.01%	1668

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ICPT Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2019, closing a stake of 16 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in ICPT in Q4 2015 and held it in 10 quarters. The position peaked at $2K in Q1 2019. 196 funds tracked by Wall St. Rank hold ICPT as of Q2 2019.

Wealthspire Advisors (Maryland) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 16 Intercept Pharmaceuticals, Inc. shares in Q2 2019, an estimated $2K.
Wealthspire Advisors (Maryland) first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 10 quarters.
Wealthspire Advisors (Maryland)'s Intercept Pharmaceuticals, Inc. position peaked at $2K in Q1 2019.
196 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.